5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
30 December 2009. Related: Conference reports.
IAS 5th Cape Town 2009
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention abstracts
20 December 2009. Related: On the web.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
5 October 2009. Related: Conference reports.
First results of new integrase compound: GSK1349572
5 October 2009. Related: Conference reports, Antiretrovirals.
Raltegravir in treatment-naive patients
5 October 2009. Related: Conference reports, Antiretrovirals.
Nevirapine vs atazanavir/ritonavir in treatment-naive patients: ARTEN study
5 October 2009. Related: Conference reports, Antiretrovirals.
Darunavir/r monotherapy studies
5 October 2009. Related: Conference reports, Antiretrovirals.
Maraviroc results similar to efavirenz when analysed using more sensitive tropism test
5 October 2009. Related: Conference reports, Antiretrovirals.
Lipid and metabolic changes with ARV combinations
5 October 2009. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Maximal suppression achieved with three drugs: no additional virological impact of raltegravir intensification
5 October 2009. Related: Conference reports, Antiretrovirals.
Tenofovir and renal safety
5 October 2009. Related: Conference reports, Side effects.
Time from seroconversion to treatment in Europe and Africa
5 October 2009. Related: Conference reports.
Pharmacokinetics of atazanavir/ritonavir during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Presentation with late stage HIV in women diagnosed during pregnancy
5 October 2009. Related: Conference reports, Pregnancy.
Low transmission rates and favourable pregnancy outcomes reported in the DREAM study
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy rates and outcomes among women in the DART trial
5 October 2009. Related: Conference reports, Pregnancy.
Pregnancy outcomes in HAART exposed infants in Johannesburg
5 October 2009. Related: Conference reports, Paediatric care.
Efavirenz conceptions in Soweto
5 October 2009. Related: Conference reports, Pregnancy.
Impact of regimen and duration of therapy on risk of mother-to-child HIV transmission in Johannesburg
5 October 2009. Related: Conference reports, Pregnancy.
A cost-effectiveness analysis of the OCTANE trial
5 October 2009. Related: Conference reports, Pregnancy.
The PEARL study
5 October 2009. Related: Conference reports, Pregnancy.
Results from HSV-2 acyclovir studies
5 October 2009. Related: Conference reports.
Overview of TB-related studies at IAS
5 October 2009. Related: Conference reports, TB coinfection.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention abstracts
2 October 2009. Related: On the web.
5th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 19-23 July 2009, Cape Town
23 August 2009. Related: Conference reports.
Five-year survival rates of 87% without routine CD4 or laboratory monitoring in DART study demonstrate an important model for ARV access programmes
23 August 2009. Related: Conference reports, Treatment access.
Biomarkers associated with mortality: long-term follow up from SMART
23 August 2009. Related: Conference reports.
Update on Interleukin-2 clinical trials
23 August 2009. Related: Conference reports.
Influenza vaccine effective in HIV-positive adults
23 August 2009. Related: Conference reports.
Reducing HIV transmission during breastfeeding
23 August 2009. Related: Conference reports, Pregnancy.
Treating children previously exposed to single dose nevirapine
23 August 2009. Related: Conference reports, Paediatric care.